eCommons@AKU
Section of Otolaryngology, Head & Neck Surgery

Department of Surgery

3-2020

Ewing sarcoma of larynx: A rare case in a 5-year-old boy
Hamdan Ahmed Pasha
Aga Khan University, hamdan.pasha@aku.edu

Shayan Khalid
Aga Khan University, shayan.khalid@aku.edu

Muhammad Wasif
Aga Khan University

Moghira Siddiqui
Aga Khan University, moghira.siddiqui@aku.edu

Nasir Ud Din
Aga Khan University, nasir.uddin@aku.edu

Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_surg_otolaryngol_head_neck
Part of the Otolaryngology Commons, Pathology Commons, and the Surgery Commons

Recommended Citation
Pasha, H. A., Khalid, S., Wasif, M., Siddiqui, M., Ud Din, N. (2020). Ewing sarcoma of larynx: A rare case in a
5-year-old boy. Turkish Archives of Otorhinolaryngology, 58(1), 65-68.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_otolaryngol_head_neck/110

65

Turkish Archives of Otorhinolaryngology

Turk Arch Otorhinolaryngol 2020; 58(1): 65-8

Ewing Sarcoma of Larynx: A Rare Case in a
5-Year-Old Boy
Case Report

Abstract

Hamdan Ahmed Pasha , Shayan Khalid Ghaloo
Siddiqui , Nasir Ud Din

Cite this article as: Pasha HA, Ghaloo SK,
Wasif M, Siddiqui MI, Din NU. Ewing Sarcoma
of Larynx: A Rare Case in a 5-Year-Old Boy.
Turk Arch Otorhinolaryngol 2020; 58(1): 65-8.
Corresponding Author:
Muhammad Wasif; wasif_siddiq313@yahoo.com
Received Date: 06.10.2019
Accepted Date: 26.12.2019
Available Online Date: 26.03.2020
Content of this journal is licensed under a Creative
Commons Attribution 4.0 International License.
Available online at www.turkarchotolaryngol.net

DOI: 10.5152/tao.2020.4839

, Moghira Iqbaluddin

Department of Otorhinolaryngology-Head and Neck Surgery, Aga Khan University Hospital Karachi, Karachi, Pakistan

Ewing Sarcoma of the head and neck region is an extremely rare entity. Treatment usually involves surgery,
chemotherapy and radiotherapy in varying sequences.
We present the third case to date of Ewing sarcoma
of the larynx in a paediatric population. A 5-year-old
boy presented to emergency room with acute respiratory distress. Computerized tomography scan showed
a mass in the supraglottis; he was intubated using vid-
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Children presenting to pediatric emergency with
stridor is not uncommon. Most common causes of
stridor in pediatric population are laryngomalacia,
subglottic stenosis or vocal cord paralysis (1). We
report the case of a 5-year-old boy who presented
with stridor to the emergency room and was found
to have a laryngeal mass that was excised and diagnosed as Ewing sarcoma. The clinical presentation,
management and outcome has been discussed with
a review of the literature. Only two pediatric cases
of Ewing sarcoma have been previously reported
more than two to three decades ago (2). Overall, a
total of seven cases with Ewing sarcoma have been
reported to occur in the larynx.

Case Presentation

A 5-year-old boy presented to the emergency department with progressive change in his voice for
eight months, difficulty in breathing for six months
and stridor for three days. He had no difficulty in
swallowing. The mother of the child also denied
any history of foreign body ingestion, intubation,
trauma or fever. On examination, the child was
anxious, restless and in moderate respiratory dis-

eolaryngoscope and tracheostomy was avoided, mass
was removed by cold dissection. Final histopathologic
examination revealed Ewing sarcoma. Further workup
showed no systemic metastasis. Patient was advised
adjuvant therapy which the family refused. Currently
he is doing fine on 2 years of follow-up.
Keywords: Ewing sarcoma, larynx, paediatric, surgery

tress. Nebulization with epinephrine and steroid
injection improved the condition of the child with
reduced work of breathing and resulted in a better
respiratory rate. The child was then moved for a
computerized tomography (CT) scan that showed
a rounded soft tissue density mass of 18x16 mm
in the supraglottic region and the ventricles, it was
abutting the epiglottis, likely representing papilloma (Figure 1).
The child was moved to the operating room. He
was examined with the help of a videolaryngoscope, and a mass of about 2x2 cm was seen to
obstruct the upper airway (Figure 2). He was
intubated and tracheotomy was avoided. The tumor was firm in consistency and was excised in
piecemeal with cold knife technique (Figure 3).
The patient was extubated uneventfully, with no
stridor or dyspnea. He was observed for 24 hours
and discharged in stable condition on the second
post-operative day. Histopathological examination revealed squamous mucosa covered fragments showing infiltration by a neoplastic lesion
arranged in diffuse sheets. The tumor cells were
uniform, round, and exhibited hyperchromatic nu-
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Figure 1. CT scan (coronal and sagittal views) showing mass in
supraglottis
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Figure 4. a-d. Low and high power examination of laryngeal Ewing
sarcoma. Arrow in Figure a shows overlying stratified squamous
epithelial lining. The tumor is arranged in diffuse sheets and has
uniform round cells with hyperchromatic nuclei (H&E stain)
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Figure 2. Video laryngoscopy showing laryngeal mass
Figure 5. a, b. Abundant cytoplasmic granules are seen on PAS stain
(a) and tumors cells showed strong membranous staining for CD99
immunohistochemical stain (b)

Figure 3. Adequate airway post excision of the laryngeal mass

clei with scant eosinophilic cytoplasm (Figures 4 a-d). Increased
mitotic figures were seen. Histologically, differential diagnoses
of embryonal rhabdomyosarcoma, acute lymphoblastic lymphoma/leukemia and Ewing sarcoma were considered. A Periodic
acid-Schiff (PAS) stain highlighted abundant cytoplasmic glycogen granules (Figure 5a). Immunohistochemical staining with
CD99 was strongly membranous positive (Figure 5b) and cyclin
D1 showed strong nuclear positivity. Desmin, leukocyte common antigen (LCA) and terminal deoxynucleotidyl transferase

(TdT) were negative, thus ruling out rhabdomyosarcoma and
acute lymphoblastic lymphoma, respectively. Cytokeratin AE1/
AE3 and p63 were negative, ruling out an undifferentiated carcinoma. CD117 was performed to rule out myeloid sarcoma
and was negative. Histological features favored Ewing sarcoma.
Fluorescence in situ hybridization (FISH) for Ewing sarcoma
break apart (EWSR1) probe was performed and revealed nuclei in which one pair of the probe signals was split apart due
to a rearrangement in the EWSR1 gene (green arrows, Figure
6). The FISH result confirmed the diagnosis of Ewing sarcoma.
For further management, the patient was referred to paediatric
oncology. His metastatic workup was done with bone scan and
bone marrow biopsy. The results were negative with no evidence
of spread of the disease. The patient was advised adjuvant chemotherapy with radiation, but the parents refused. He is under
regular follow-up and at two years of follow-up has shown no
symptoms or signs of recurrence. Informed consent was taken
from the father to report this case.

Discussion

Ewing sarcoma is the second most frequent primary bone malignancy after osteosarcoma, mostly occurring in the flat bones of
the axial skeleton and in the long bones. It has been divided into
classic Ewing sarcoma of the bone, extraskeletal Ewing sarcoma
(EES), and malignant peripheral primitive neuroectodermal tu-
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The other five cases of laryngeal Ewing sarcoma occurred in
adults with age ranging from 33 to 74 years (mean 54.6 years;
median 53 years) (3-7). Three were male and two were female.
Yang and Hong (3) reported laryngeal Ewing sarcoma in a
74-year-old male. The patient presented with acute respiratory
distress; after emergency tracheostomy, workup revealed Ewing
sarcoma. He underwent laryngectomy, neck dissection and adjuvant radiation. The patient stayed disease-free for six months.

Figure 6. LSI EWSR1 Dual Color, Break Apart Rearrangement
Probe revealed split apart green and red signals (black arrows)
confirming the diagnosis of Ewing sarcoma along with morphology
and immunoprofile

mor (pNET) (8). The debate on the exact cell of origin of Ewing
sarcomas is yet unresolved. Histological features suggest a poorly
differentiated tumor having both mesenchymal and neuroectodermal features. Head and neck Ewing sarcoma represents less
than 9% of all Ewing sarcomas, with mandibular tumors being
the most common (9). In a recent 43-year review from the Mayo
Clinic only 17 patients had Ewing sarcoma in the head and neck
region; of these most were found in bony structures, namely in the
cervical spine and the skull (10). Majority of their patients were
treated with surgery with or without adjuvant chemoradiation in
varying sequences. They reported no case arising primarily in the
larynx. Majority of the patients were adults and only one patient
was under five years of age. Ellis et al. (11) used the Surveillance,
Epidemiology, and End Results (SEER) database to publish the
largest series of Ewing sarcoma in the head and neck. They found
Ewing sarcomas in the head and neck to be smaller, with lower
rates of metastasis at presentation when compared to those originating at other sites; but did not deem it to be a separate clinical
entity, and the prognosis of Ewing sarcoma in the head and neck
was not different than that at other primary sites. The presence
or absence of metastasis is a key prognostic factor for Ewing sarcoma. In the head and neck Ewing sarcomas, the frequency of
metastasis at presentation is lower, although larger tumor volumes
are associated with worse survival rates (12-14).
The youngest pediatric patient of laryngeal Ewing sarcoma was
a 1-day-old male baby who presented with respiratory distress
and stridor at the time of birth. Laryngoscopy and bronchoscopy showed a right sided solitary mass causing obstruction of the
glottis. A biopsy was taken for frozen section which revealed an
undifferentiated malignant tumor. His metastatic workup was
negative. A tracheostomy was performed as the tumor was obstructing the airway. A total laryngectomy was performed on the
10th day of life. Final diagnosis was a malignant undifferentiated
sarcoma consistent with an extraskeletal Ewing sarcoma. Patient
was alive and free of disease 2 years after the surgery (1). The
second pediatric case was a 9-month-old male baby. A laryngectomy was done and patient received chemotherapy as well. The
tumor recurred locally (2).

Another 68-year-old male was reported with a 3-month history of hoarseness and aphonia. He had neoplastic infiltration
occupying the anterior commissure, both vocal cords and the
laryngeal ventricles. The patient refused laryngectomy and underwent induction chemotherapy followed by radiation. Complete regression of the tumor was seen and patient did well at 30
months follow-up (4).
The current treatment line for Ewing sarcoma includes six cycles of neoadjuvant chemotherapy, followed by local therapy, i.e.,
surgery, radiotherapy or both, with continued chemotherapy for
a year. The initial evaluation before treatment should include imaging which can assess the degree of compromised bone cortex
and its relation to adjacent anatomic landmarks. Magnetic resonance imaging remains the gold standard for radiographic characterization of Ewing sarcoma as it can determine the relationship of the tumor with the adjacent structures. Patients should
also receive chest CT and technetium Tc 99m bone scanning or
PET scanning in order to identify metastatic lesions.

Conclusion

Ewing sarcoma of the larynx is a rare entity especially in the
paediatric age group. The diagnostic challenge lies in differentiating this tumor from other causes of round blue cell tumors.
Extensive immunostaining and FISH confirm the diagnosis.
Treatment protocols are not uniform owing to the rare occurrence. Our patient was managed by surgery alone and no recurrence was seen on two years follow-up.
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